Impaired cardiometabolic responses to glucagon-like peptide 1 in obesity and type 2 diabetes mellitus

Keyphrases

• AMPK Signaling 10%
• Beneficial Effects 10%
• Blood Flow 10%
• Cardiac Tissue 10%
• Cardiometabolic Disease 100%
• Cardiometabolic Effects 10%
• Consumption Flow 10%
• During Exercise 10%
• Glucagon-like 100%
• Glucagon-like peptide-1 Receptor (GLP-1R) 10%
• Insulin-like 10%
• Myocardial Glucose Uptake 30%
• Myocardial Ischemia 10%
• Myocardial Oxygen Consumption 10%
• Non-associated 10%
• Obesity 100%
• Ossabaw Swine 10%
• P38 MAPK Pathway 10%
• P38 Mitogen-activated Protein Kinase (p38 MAPK) 10%
• PKA Pathway 10%
• R-expressions 10%
• Resting Conditions 10%
• Swine 30%
• Type 2 Diabetes Mellitus (T2DM) 100%

Medicine and Dentistry

• AMPK Signaling 11%
• Beinaglutide 11%
• Blood Flow 11%
• Glucagon Like Peptide 1 100%
• Glucose Uptake 33%
• Heart Muscle Ischemia 11%
• Heart Muscle Oxygen Consumption 11%
• MAPK Signaling 11%
• Maturity Onset Diabetes of the Young 100%
• p38 Mitogen-Activated Protein Kinase 22%
• Type 2 Diabetes 44%

Pharmacology, Toxicology and Pharmaceutical Science

• Beinaglutide 11%
• Glucagon-Like Peptide-1 100%
• Heart Muscle Ischemia 11%
• Non Insulin Dependent Diabetes Mellitus 100%
• Pig 44%